how hantavirus presents over time
Acute vs delayed hantavirus presentations
| Feature | Acute presentation | Delayed / atypical |
|---|---|---|
| Time to symptoms | 1–8 weeks (typical 2–4) | Atypical or biphasic onset rare |
| Course | Days–weeks; clearly defined phases | Prolonged convalescence (months) reported, particularly post-PUUV |
| Hallmark features | Fever, myalgia, then organ-specific syndrome | Persistent renal proteinuria, exertional dyspnoea, fatigue |
| Chronic infection | Not described in humans | Not described — humans clear infection |
| Long COVID-style sequelae? | Uncommon but reported | Reported especially after severe HPS or HTNV-HFRS |
Hantavirus disease in humans is almost always an acute illness with well-defined phases. Unlike herpes or hepatitis viruses, hantaviruses do not establish chronic infection in the human host — once the immune response clears the virus, it is gone. But "acute" does not mean "short": some patients experience prolonged convalescence with measurable physiological deficits for months.
Acute (typical) presentation. Both HPS and HFRS unfold over days to weeks. Incubation is 1–8 weeks (most cases at 2–4). After a 3–7 day prodrome of fever and myalgia, patients develop the organ-specific syndrome — capillary leak in the lungs (HPS) or the five-phase renal course (HFRS). With supportive care, most survivors are discharged within 1–3 weeks.
Delayed and atypical presentations. A meaningful minority of survivors report sequelae weeks to months after discharge: persistent fatigue, exertional dyspnoea, mild proteinuria, and cognitive complaints. These patterns are best documented after severe Puumala-virus HFRS in Fennoscandia, where long-term follow-up cohorts exist; smaller case series describe similar findings after severe HPS. Atypical biphasic onsets (a brief illness, recovery, then a second more severe phase) have been reported but are uncommon.
Chronic hantavirus infection? Not in humans. Hantaviruses persist lifelong in their reservoir rodents, but in humans the immune response clears the infection. There is no established hantavirus reactivation syndrome, no documented hantavirus oncogenesis, and no role for chronic antiviral therapy.
Operational implications. Acute presentation is the rule and the priority — prompt diagnosis and intensive care save lives. Convalescent care should screen for persistent renal and pulmonary deficits and offer rehabilitation; the majority of patients who survive the acute illness recover fully over months.